Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 49 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 55 | 2,499−11%/yr | −11%/yr | 2.80.9× | 7% | 2,340 in 2030−1.1%/yr |
| Lumbar fusion | 60 | 2,354−6.6%/yr | −6.6%/yr | 2.71.0× | 2% | 2,220 in 2030−1%/yr |
| Cervical fusion & disc arthroplasty | 24 | 1,338−6.2%/yr | −6.2%/yr | 1.51.1× | 3% | 1,110 in 2030−3%/yr |
| Kyphoplasty & vertebroplasty | 11 | 1,216−8.7%/yr | −8.7%/yr | 1.41.0× | 12% | 1,000 in 2030−3.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 430 | 65,322−6%/yr | −6%/yr | 73.00.9× | 40% | 65,100 in 20300%/yr |
| Skin substitutes & wound grafts | 37 | 10,345+8%/yr | +8%/yr | 6.50.8× | 46% | 13,300 in 2030+4.3%/yr |
| Bone graft & orthobiologics | 27 | 796−14%/yr | −14%/yr | 0.91.5× | 3% | 740 in 2030−1.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 128 | 7,269−3.7%/yr | −3.7%/yr | 8.10.9× | 75% | 8,240 in 2030+2.1%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 9 | 674−6.2%/yr | −6.2%/yr | 0.70.6× | 49% | 680 in 20300%/yr |
| Spinal cord & DRG stimulation | 13 | 535−8.6%/yr | −8.6%/yr | 0.60.8× | 51% | 480 in 2030−1.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 59 | 5,586−14%/yr | −14%/yr | 6.91.7× | 71% | 4,770 in 2030−2.6%/yr |
| Peripheral arterial intervention | 34 | 4,986−13%/yr | −13%/yr | 5.61.4× | 65% | 5,540 in 2030+1.8%/yr |
| Superficial venous ablation | 44 | 2,935−15%/yr | −15%/yr | 3.31.0× | 95% | 2,850 in 2030−0.5%/yr |
| Thrombectomy, IVC filters & venous stents | 10 | 1,534−1.8%/yr | −1.8%/yr | 1.81.4× | 18% | 1,770 in 2030+2.4%/yr |
| Carotid revascularization | 13 | 961−9.4%/yr | −9.4%/yr | 1.11.0× | 0% | 870 in 2030−1.7%/yr |
| Aortic endografts (EVAR/TEVAR) | 0 | 381−11%/yr | −11%/yr | 0.51.0× | 0% | 370 in 2030−0.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 38 | 4,810−7%/yr | −7%/yr | 6.11.0× | 4% | 4,960 in 2030+0.5%/yr |
| Cholecystectomy & appendectomy | 39 | 3,319−9.3%/yr | −9.3%/yr | 4.10.9× | 1% | 3,010 in 2030−1.6%/yr |
| Colorectal resection | 3 | 1,300−11%/yr | −11%/yr | 1.60.9× | 0% | 1,170 in 2030−1.7%/yr |
| Antireflux & hiatal hernia surgery | 3 | 585−8.8%/yr | −8.8%/yr | 0.70.9× | 0% | 540 in 2030−1.4%/yr |
| Breast reconstruction | 1 | 303−11%/yr | −11%/yr | 0.40.8× | 0% | 190 in 2030−7.5%/yr |
| Bariatric surgery | 0 | 161−24%/yr | −24%/yr | 0.20.9× | 0% | 130 in 2030−3.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 94 | 4,688−5.4%/yr | −5.4%/yr | 5.61.0× | 6% | 4,480 in 2030−0.8%/yr |
| BPH procedures | 40 | 3,700−3.6%/yr | −3.6%/yr | 4.30.9× | 29% | 3,320 in 2030−1.8%/yr |
| Hysterectomy, hysteroscopy & ablation | 15 | 2,577−6%/yr | −6%/yr | 3.41.2× | 11% | 2,550 in 2030−0.1%/yr |
| Incontinence, prolapse & sacral neuromodulation | 25 | 1,789−6.7%/yr | −6.7%/yr | 2.10.9× | 4% | 1,480 in 2030−3.1%/yr |
| Prostatectomy & nephrectomy | 10 | 897−4.5%/yr | −4.5%/yr | 1.20.8× | 0% | 1,150 in 2030+4.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 14 | 2,062−11%/yr | −11%/yr | 2.50.7× | 64% | 1,990 in 2030−0.6%/yr |
| Ear tubes & middle ear surgery | 3 | 373−9.8%/yr | −9.8%/yr | 0.41.4× | 17% | 330 in 2030−2.1%/yr |
| Cochlear implants | 3 | 130−0.5%/yr | −0.5%/yr | 0.20.8× | 0% | 210 in 2030+8.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 102 | 5,736−6.4%/yr | −6.4%/yr | 7.31.0× | 5% | 5,320 in 2030−1.2%/yr |
| Tumor & fibroid embolization | 7 | 565+12%/yr | +12%/yr | 0.71.4× | 78% | 1,300 in 2030+15%/yr |
| Tumor ablation | 0 | 228−3.3%/yr | −3.3%/yr | 0.30.8× | 0% | 370 in 2030+8.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 215 | 22,586+13%/yr | +13%/yr | 26.20.9× | 68% | 36,200 in 2030+8.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 80 | 4,354−7%/yr | −7%/yr | 5.41.0× | 1% | 3,930 in 2030−1.7%/yr |
| LAA occlusion & loop recorders | 82 | 3,065+2.7%/yr | +2.7%/yr | 3.11.0× | 17% | 4,880 in 2030+8.1%/yr |
| EP ablation | 66 | 2,682+0.7%/yr | +0.7%/yr | 2.60.8× | 0% | 4,190 in 2030+7.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 162 | 6,045−10%/yr | −10%/yr | 5.60.9× | 1% | 6,100 in 2030+0.2%/yr |
| Structural heart (TAVR, TEER) | 94 | 1,656+3%/yr | +3%/yr | 1.60.9× | 0% | 2,670 in 2030+8.3%/yr |
| Mechanical circulatory support | 1 | 533−7.6%/yr | −7.6%/yr | 0.61.0× | 0% | 590 in 2030+1.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Aneurysm & intracranial embolization | 7 | 386+9.3%/yr | +9.3%/yr | 0.51.1× | 0% | 640 in 2030+8.7%/yr |
| Stroke thrombectomy | 9 | 361−2.8%/yr | −2.8%/yr | 0.41.1× | 0% | 360 in 2030−0.1%/yr |
| DBS & VNS | 2 | 246−8.8%/yr | −8.8%/yr | 0.30.8× | 0% | 130 in 2030−10%/yr |
| CSF shunts | 0 | 130−12%/yr | −12%/yr | 0.20.8× | 0% | 290 in 2030+14%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 304 | 41,610−7.1%/yr | −7.1%/yr | 48.20.7× | 76% | 38,700 in 2030−1.2%/yr |
| Vitreoretinal surgery | 23 | 1,526−8.8%/yr | −8.8%/yr | 1.80.7× | 29% | 1,320 in 2030−2.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 560 | 87,395−7.5%/yr | −7.5%/yr | 108.40.9× | 36% | 82,100 in 2030−1%/yr |
| ERCP & endoscopic ultrasound | 53 | 3,574+1.2%/yr | +1.2%/yr | 4.31.1× | 1% | 4,510 in 2030+4%/yr |
| Bronchoscopy & lung nodule | 41 | 2,711−0.1%/yr | −0.1%/yr | 3.30.9× | 0% | 4,390 in 2030+8.4%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.